ONCOGENEX PHARMACEUTICALS IN - 68230A106

Sector: No information yet · Industry: No information yet
Website: No information yet · Social: No information yet

Company profile

Description is not available for this instrument yet.

Quarter snapshot

Latest / Compare
Q2 2014 · Q1 2014
Value (USD)
Total reported value ($000)
$9.936M
QoQ value delta ($000)
-$72.3M (-87.92%)
Implied price effect (QoQ)
-68.25%
Shares
Total shares
2,663,767
QoQ shares delta
-4,335,938 (-61.94%)
Total shares held by funds (by quarter)

Top holders (Q2 2014)

Top 25 only Full list
Early Q2 2017 data: only 1 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
BlackRock Institutional Trust Company, N.A. 2,549 683,312 0.0%
First Eagle Investment Management, LLC 2,144 574,712 0.01%
TFS CAPITAL LLC 1,344 360,260 0.11%
VANGUARD GROUP INC 1,270 340,393 0.0%
BLACKROCK ADVISORS LLC 780 209,100 0.0%
BlackRock Group LTD 424 113,556 0.0%
Tekla Capital Management LLC 422 113,100 0.04%
BlackRock Fund Advisors 179 48,063 0.0%
CREDIT SUISSE AG/ 150 40,142 0.0%
DIMENSIONAL FUND ADVISORS LP 142 38,114 0.0%
LMR Partners LLP 119 31,754 0.01%
TOCQUEVILLE ASSET MANAGEMENT L.P. 112 30,000 0.0%
STONERIDGE INVESTMENT PARTNERS LLC 71 19,163 0.01%
ROCKEFELLER FINANCIAL SERVICES INC 54 14,569 0.0%
BLB&B Advisors, LLC 54 14,350 0.01%
CORNERSTONE CAPITAL MANAGEMENT HOLDINGS LLC. 50 13,600 0.0%
BlackRock Japan Co. Ltd 40 10,754 0.0%
Wunderlich Securities, Inc. 23 6,300 0.01%
BlackRock Investment Management, LLC 9 2,525 0.0%